» Articles » PMID: 19230600

Diclofenac and Ketoprofen Liver Toxicity in Rat

Overview
Date 2009 Feb 24
PMID 19230600
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In the last years there appeared many articles about the adverse influence of non-steroidal anti-inflammatory drugs on the liver and heart. This study is concerned with the influence of the duration of treatment with diclofenac and ketoprofen on the macroscopic and microscopic changes in the liver, lungs, heart, and kidneys in rats. Experiments were carried out on mature Wistar strain rats. Animals of test groups received diclofenac and ketoprofen in a dose of 8 mg/kg/day (equivalent to the therapeutic dose for man) during 7 per os (p.o.) or 28 days intraperitoneally (i.p.), whereas controls received physiological solution p.o. A high morbidity was observed in the animals receiving diclofenac p.o. and somewhat lower in those treated with ketoprofen. On the other hand, the rats got through the 28-day i.p. treatment with both drugs mainly without significant complications. Macroscopic examinations revealed some changes in treated rats: distension of the stomach, ascites, fibrin deposits on the internal organs, lung effusion and the changes in color and structure of the liver. These changes were more frequent in the group of rats receiving diclofenac for the 7 days compared with those that received ketoprofen for the same time. It may be thought that the high mortality and macroscopic changes in the internal organs of experimental animals are a consequence of the microscopic changes in the liver and its lowered function.

Citing Articles

Hepatoprotective and nephroprotective effects of Ruiz and Pav. on diclofenac-induced toxicity in rats.

Mendoza-Fernandez P, Silva-Correa C, Torre V, Aspajo-Villalaz C, Calderon-Pena A, Rosario-Chavarri J Vet World. 2023; 16(9):1933-1939.

PMID: 37859960 PMC: 10583873. DOI: 10.14202/vetworld.2023.1933-1939.


Protective impacts of leaf extract from Taif area against induced hepato-renal toxicity: role of antioxidants, inflammation, apoptosis, and anti-oxidative stress biomarkers.

Soliman M, Elshehawei A, Althobaiti S, Sayed S Toxicol Res (Camb). 2023; 12(4):685-692.

PMID: 37663806 PMC: 10470349. DOI: 10.1093/toxres/tfad058.


Carvacrol Exerts Anti-Inflammatory, Anti-Oxidative Stress and Hepatoprotective Effects Against Diclofenac-Induced Liver Injury in Male Rats.

Barzan M, Heydari M, Mirshekari-Jahangiri H, Firouzi H, Dastan M, Najafi M Int J Prev Med. 2023; 14:61.

PMID: 37351047 PMC: 10284240. DOI: 10.4103/ijpvm.ijpvm_178_21.


Impacts of Color Coding on Programming Learning in Multimedia Learning: Moving Toward a Multimodal Methodology.

Liu Y, Ma W, Guo X, Lin X, Wu C, Zhu T Front Psychol. 2021; 12:773328.

PMID: 34925175 PMC: 8677832. DOI: 10.3389/fpsyg.2021.773328.


Carvacrol exerts nephroprotective effect in rat model of diclofenac-induced renal injury through regulation of oxidative stress and suppression of inflammatory response.

Nouri A, Izak-Shirian F, Fanaei V, Dastan M, Abolfathi M, Moradi A Heliyon. 2021; 7(11):e08358.

PMID: 34816045 PMC: 8591494. DOI: 10.1016/j.heliyon.2021.e08358.


References
1.
Ishizaki T, Sasaki T, Suganuma T, Horai Y, Chiba K, Watanabe M . Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration. Eur J Clin Pharmacol. 1980; 18(5):407-14. DOI: 10.1007/BF00636794. View

2.
Seymour R, Kelly P, Hawkesford J . Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain. Clin Drug Investig. 2008; 15(4):279-84. DOI: 10.2165/00044011-199815040-00003. View

3.
Tang W, Stearns R, Kwei G, Iliff S, Miller R, Egan M . Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism. J Pharmacol Exp Ther. 1999; 291(3):1068-74. View

4.
Reyes-Gordillo K, Muriel P, Castaneda-Hernandez G, Favari L . Pharmacokinetics of diclofenac in rats intoxicated with CCL4, and in the regenerating liver. Biopharm Drug Dispos. 2007; 28(8):415-22. DOI: 10.1002/bdd.569. View

5.
Walker J, Carmody J, Vial J, Day R . Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". Arthritis Rheum. 1997; 40(11):1944-54. DOI: 10.1002/art.1780401105. View